Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized phase IV comparison of Cervarix versus Gardasil immune responses in UK adolescent girls
2008-006773-32Phase 4Completed
- Sponsor
- Health Protection Agency
- Start
- Apr 2009
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial in human papillomavirus infection and Cervical Cancer (CC) comparing Cervarix with Gardasil (2 arms). Primary endpoints: HPV serologic immune response up to one year after first vaccine dose and Comparative HPV-specific immune responses against oncogenic HPV types. Started Apr 2009; status: completed.
02
Drugs
human papillomavirus type 16 L1 capsid protein antigenqHPV vaccine
03
Conditions
human papillomavirus infectionCervical Cancer (CC)
Beyond the preview
Go deeper on 2008-006773-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-006773-32.